Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification

Overview of attention for article published in Breast Cancer Research and Treatment, March 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 39 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 4 X users, with an upper bound of 9,560 followers.

RT @NeoGenomics: ICYMI: Paper in #Springer on #BreastCancer with HER2 equivocal amplification indicates: Some breast cancer cases tested fo…

23 Apr 2018

Reply Repost Favourite

RT @NeoGenomics: ICYMI: Paper in #Springer on #BreastCancer with HER2 equivocal amplification indicates: Some breast cancer cases tested fo…

11 Apr 2018

Reply Repost Favourite

ICYMI: Paper in #Springer on #BreastCancer with HER2 equivocal amplification indicates: Some breast cancer cases tested for HER2 are equivocal by both IHC & FISH; half of FISH equivocal cases converted to HER2+ upon alternative testing. See conclusion:

10 Apr 2018

Reply Repost Favourite

RT @NeoGenomics: New paper in #Springer on #BreastCancer with HER2 equivocal amplification indicates: Some breast cancer cases tested for H…

03 Apr 2018

Reply Repost Favourite

RT @NeoGenomics: New paper in #Springer on #BreastCancer with HER2 equivocal amplification indicates: Some breast cancer cases tested for H…

27 Mar 2018

Reply Repost Favourite

New paper in #Springer on #BreastCancer with HER2 equivocal amplification indicates: Some breast cancer cases tested for HER2 are equivocal by both IHC & FISH; half of FISH equivocal cases converted to HER2+ upon alternative testing. See conclusion: ht

27 Mar 2018

Reply Repost Favourite